SOURCE: Smith & Nephew PLC

August 20, 2007 10:25 ET

SMITH & NEPHEW PLC ANNOUNCES INVESTOR VISIT TO SN ENDO

London, UK--(Marketwire - August 20, 2007) -


Investor visit to Smith & Nephew Endoscopy

20 August 2007

Smith & Nephew plc, (LSE: SN, NYSE: SNN), the global medical
technology business, will be holding a visit for institutional
investors and analysts at the global headquarters of the company's
Endoscopy business in Boston, Massachusetts, on Tuesday 18 September
2007.

The visit will be hosted by Chief Executive, David Illingworth, and
Mike Frazzette, President of Smith & Nephew Endoscopy. During the
visit guests will have the opportunity to meet senior management and
receive presentations from the heads of the Endoscopy business.

The main presentations of the event will be webcast live on Smith &
Nephew's corporate website at www.smith-nephew.com and will begin at
1.15pm BST/7.15am CST/8.15am EST on Tuesday 18 September 2007. An
archive of these presentations will be available on the website
shortly after the close.

Enquiries

Julie Allen Tel: +44 (0) 20 7401 7646
Corporate Affairs Co-ordinator

About us


Smith & Nephew (LSE: SN.L; NYSE: SNN) is one of the world's leading
medical device companies, specialising in Orthopaedic Reconstruction,
Orthopaedic Trauma and Clinical Therapies, Endoscopy and Advanced
Wound Management. Smith & Nephew is a global leader in arthroscopy and
advanced wound management and is one of the leading global
orthopaedics companies.


Smith & Nephew is dedicated to helping improve people's lives. The
company prides itself on the strength of its relationships with its
surgeon and healthcare professional customers, with whom its name is
synonymous with the highest standards of performance, innovation and
trust. The company has over 9,600 employees and operates in 31
countries around the world, generating sales of $2.8 billion.


Forward-Looking Statements



This press release contains certain "forward-looking statements"
within the meaning of the US Private Securities Litigation Reform Act
of 1995. In particular, statements regarding expected revenue growth
and trading margins discussed under "Outlook" are forward-looking
statements as are discussions of our product pipeline. These
statements, as well as the phrases "aim", "plan", "intend",
"anticipate", "well-placed", "believe", "estimate", "expect",
"target", "consider" and similar expressions, are generally intended
to identify forward-looking statements. Such forward-looking
statements involve known and unknown risks, uncertainties and other
important factors (including, but not limited to, the outcome of
litigation, claims and regulatory approvals) that could cause the
actual results, performance or achievements of Smith & Nephew, or
industry results, to differ materially from any future results,
performance or achievements expressed or implied by such
forward-looking statements. Please refer to the documents that Smith &
Nephew has filed with the U.S. Securities and Exchange Commission
under the U.S. Securities Exchange Act of 1934, as amended, including
Smith & Nephew's most recent annual report on Form 20F, for a
discussion of certain of these factors.

All forward-looking statements in this press release are based on
information available to Smith & Nephew as of the date hereof. All
written or oral forward-looking statements attributable to Smith &
Nephew or any person acting on behalf of Smith & Nephew are expressly
qualified in their entirety by the foregoing. Smith & Nephew does not
undertake any obligation to update or revise any forward-looking
statement contained herein to reflect any change in Smith & Nephew's
expectation with regard thereto or any change in events, conditions or
circumstances on which any such statement is based.



                  This information is provided by RNS
        The company news service from the London Stock Exchange